Although the roles of TLSs and CD8 + T-cells in tumor biology and antitumor immunity have been widely studied, the potential clinical translation is still hampered by the heterogeneity of TLSs and their complex relationship with CD8 + T-cells. The gene discussed is CD8A; the disease is neoplasm.